封面
市场调查报告书
商品编码
1890953

生物材料市场按材料类型、应用、技术、最终用户和地区划分

Biomaterials Market, By Material Type, By Application, By Technology, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年,生物材料市场价值将达到 2,082.3 亿美元,到 2032 年将达到 5,779.3 亿美元,2025 年至 2032 年的复合年增长率为 15.8%。

报告内容 报告详情
基准年: 2024 2025年市场规模: 2082.3亿美元
历史数据时期: 2020年至2024年 预测期: 2025年至2032年
预测期(2025-2032年)复合年增长率: 15.80% 2032 年的预测值: 5779.3亿美元

全球生物材料市场是一个快速扩张的领域,它融合了材料科学、生物技术和医疗创新。

生物材料涵盖了种类繁多的天然和合成物质,这些物质旨在与生物系统相互作用,应用于医疗领域,例如植入、药物传输系统、组织工程支架、诊断设备等。这些材料经过工程设计,具有生物相容性,确保它们在人体内有效发挥作用,而不会引起不良反应。

该市场涵盖多种类别,例如钛合金等金属生物材料、羟基磷灰石等陶瓷生物材料、包括可生物降解聚合物在内的聚合物生物材料、结合多种性能的复合材料等。慢性病日益增多、全球人口老化、医疗保健成本不断上涨以及材料科学的持续技术进步正在推动该领域的显着增长。

此外,奈米技术、3D列印和智慧材料的融合正在革新生物材料的应用,从而推动个人化医疗和再生医学的发展。该市场服务于众多终端用户,包括医院、诊所、研究机构和製药公司,其应用范围涵盖整形外科和心血管植入、创伤治疗和组织再生解决方案等。

市场动态

全球生物材料市场受多种关键因素驱动,这些因素正在从根本上改变医疗保健格局。其中最主要的成长要素是全球人口的快速老化。由于老年人经常需要接受与老龄化相关的医疗干预,例如关节重建、心血管装置植入和人工植牙,因此对医疗植入、义肢和再生医学解决方案的需求正在显着增长。

材料科学的技术进步,特别是智慧生物材料、生物活性材料和奈米技术增强产品的开发,正在扩大应用可能性,并透过提高生物相容性和功能性来改善患者的治疗效果。

慢性病、文明病和运动伤害的日益增多,使得各医疗专科对先进生物材料解决方案的需求显着增长。然而,该市场面临许多製约因素,可能阻碍其发展。生物材料(尤其是新型材料和应用)复杂而漫长的监管核准流程,构成了市场准入的重大障碍,并延缓了产品商业化进程,而这又需要进行大量的临床试验和安全性评估。

生物材料的高昂研发和製造成本以及严格的品管要求限制了其普及和应用,尤其是在开发中国家。此外,长期生物相容性、潜在的不良反应以及复杂的生物相互作用等问题也构成持续的挑战。儘管有这些限制,但由于再生医学、组织工程和个人化医疗解决方案等领域新应用的兴起,生物材料仍蕴藏着巨大的市场机会。

本次调查的主要特点

  • 本报告以 2024 年为基准年,对全球生物材料市场进行了详细分析,并给出了预测期(2025-2032 年)内的市场规模(十亿美元)和復合年增长率(%)。
  • 它还重点介绍了各个细分市场的潜在商机,并说明了该市场具有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、阻碍因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
  • 本报告根据以下参数对全球生物材料市场的主要企业进行了概况介绍:公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 这份全球生物材料市场报告的目标受众是产业内的各种相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过分析全球生物材料市场中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要

第三章 市场动态、监理及趋势分析

  • 市场动态
  • 司机
  • 抑制因素
  • 机会
  • 影响分析
  • 重大进展
  • 法规环境
  • 产品上市及核准
  • PEST分析
  • 波特分析
  • 併购趋势
  • 产业趋势

4. 2020-2032年全球生物材料市场(依材料类型划分)

  • 金属生物材料
  • 高分子生物材料
  • 陶瓷生物材料
  • 天然生物材料

5. 2020-2032年全球生物材料市场(依应用领域划分)

  • 整形外科
  • 心血管系统
  • 牙科
  • 整形外科
  • 创伤治疗
  • 组织工程
  • 神经系统疾病
  • 眼科
  • 药物输送系统

6. 2020-2032年全球生物材料市场(依技术划分)

  • 3D列印
  • 奈米科技
  • 静电纺丝
  • 生物列印
  • 水凝胶技术

7. 2020-2032年全球生物材料市场(依最终用户划分)

  • 医院
  • 诊所
  • 门诊手术中心
  • 研究所
  • 生物技术和製药公司

8. 2020-2032年全球生物材料市场(按地区划分)

  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 亚太其他地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第九章 竞争情势

  • BASF SE
  • Covestro AG
  • Celanese Corporation
  • Carpenter Technology Corporation
  • Royal DSM
  • Evonik Industries AG
  • Berkeley Advanced Biomaterials
  • Cam Bioceramics BV
  • Corbion NV
  • Lubrizol Corporation
  • Zimmer Biomet Holdings Inc
  • Stryker Corporation
  • Johnson and Johnson
  • Medtronic PLC
  • Boston Scientific Corporation

第十章 分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8877

Biomaterials Market is estimated to be valued at USD 208.23 Bn in 2025 and is expected to reach USD 577.93 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 208.23 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 15.80% 2032 Value Projection: USD 577.93 Bn

The global biomaterials market represents a rapidly expanding sector at the intersection of materials science, biotechnology, and healthcare innovation.

Biomaterials encompass a diverse range of natural and synthetic substances designed to interact with biological systems for medical applications, including implants, drug delivery systems, tissue engineering scaffolds, and diagnostic devices. These materials are engineered to be biocompatible, ensuring they can function effectively within the human body without causing adverse reactions.

The market spans various categories including metallic biomaterials like titanium alloys, ceramic biomaterials such as hydroxyapatite, polymeric biomaterials including biodegradable polymers, and composite materials that combine multiple properties. The increasing prevalence of chronic diseases, aging global population, rising healthcare expenditure, and continuous technological advancements in material science are driving significant growth in this sector.

Moreover, the integration of nanotechnology, 3D printing, and smart materials is revolutionizing biomaterial applications, enabling personalized medicine approaches and regenerative therapies. The market serves diverse end-users including hospitals, clinics, research institutions, and pharmaceutical companies, with applications ranging from orthopedic and cardiovascular implants to wound healing and tissue regeneration solutions.

Market Dynamics

The global biomaterials market is propelled by several key drivers that are fundamentally reshaping the healthcare landscape. The primary growth driver is the rapidly aging global population, which significantly increases the demand for medical implants, prosthetics, and regenerative medicine solutions, as elderly individuals require more frequent medical interventions for age-related conditions such as joint replacements, cardiovascular devices, and dental implants.

Technological advancements in material science, including the development of smart biomaterials, bioactive materials, and nanotechnology-enhanced products, are expanding application possibilities and improving patient outcomes through better biocompatibility and functionality.

The increasing prevalence of chronic diseases, lifestyle-related disorders, and sports injuries is creating substantial demand for advanced biomaterial solutions across various medical specialties. However, the market faces significant restraints that could impede growth trajectories. The complex and lengthy regulatory approval processes for biomaterials, particularly for novel materials and applications, create substantial barriers to market entry and delay product commercialization, requiring extensive clinical trials and safety assessments.

High development and manufacturing costs associated with biomaterials, coupled with stringent quality control requirements, limit accessibility and adoption rates, particularly in developing economies. Additionally, concerns regarding long-term biocompatibility, potential adverse reactions, and the complexity of biological interactions pose ongoing challenges. Despite these restraints, the market presents tremendous opportunities driven by emerging applications in regenerative medicine, tissue engineering, and personalized healthcare solutions..

Key Features of the Study

  • This report provides in-depth analysis of the global biomaterials market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biomaterials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include BASF SE, Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Royal DSM, Evonik Industries AG, Berkeley Advanced Biomaterials, Cam Bioceramics B.V., Corbion N.V., Lubrizol Corporation, Zimmer Biomet Holdings Inc, Stryker Corporation, Johnson and Johnson, Medtronic PLC, and Boston Scientific Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global biomaterials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biomaterials market

Market Segmentation

  • Material Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Metallic Biomaterials
    • Titanium and Titanium Alloys
    • Cobalt-Chrome Alloys
    • Others
    • Polymeric Biomaterials
    • Polymethyl Methacrylate (PMMA)
    • Polyetheretherketone (PEEK)
    • Others
    • Ceramic Biomaterials
    • Calcium Phosphate
    • Zirconia
    • Others
    • Natural Biomaterials
    • Collagen and Gelatin
    • Hyaluronic Acid
    • Others
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Orthopedic
    • Cardiovascular
    • Dental
    • Plastic Surgery
    • Wound Healing
    • Tissue Engineering
    • Neurological Disorders
    • Ophthalmology
    • Drug Delivery Systems
  • Technology Insights (Revenue, USD Bn, 2020 - 2032)
    • 3D Printing
    • Nanotechnology
    • Electrospinning
    • Bioprinting
    • Hydrogels Technology
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Research Laboratories
    • Biotechnology and Pharmaceutical Companies
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • BASF SE
    • Covestro AG
    • Celanese Corporation
    • Carpenter Technology Corporation
    • Royal DSM
    • Evonik Industries AG
    • Berkeley Advanced Biomaterials
    • Cam Bioceramics B.V.
    • Corbion N.V.
    • Lubrizol Corporation
    • Zimmer Biomet Holdings Inc
    • Stryker Corporation
    • Johnson and Johnson
    • Medtronic PLC
    • Boston Scientific Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Biomaterials Market, By Material Type
    • Global Biomaterials Market, By Application
    • Global Biomaterials Market, By Technology
    • Global Biomaterials Market, By End User
    • Global Biomaterials Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Biomaterials Market, By Material Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Metallic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Titanium and Titanium Alloys
      • Cobalt-Chrome Alloys
      • Others
  • Polymeric Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Polymethyl Methacrylate (PMMA)
      • Polyetheretherketone (PEEK)
      • Others
  • Ceramic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Calcium Phosphate
      • Zirconia
      • Others
  • Natural Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Collagen and Gelatin
      • Hyaluronic Acid
      • Others

5. Global Biomaterials Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Plastic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Wound Healing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ophthalmology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Drug Delivery Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Biomaterials Market, By Technology, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 3D Printing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nanotechnology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Electrospinning
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Bioprinting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hydrogels Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Biomaterials Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Biomaterials Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Material Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Material Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Material Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Material Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Material Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Material Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covestro AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Celanese Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Carpenter Technology Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Royal DSM
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Evonik Industries AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Berkeley Advanced Biomaterials
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cam Bioceramics B.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Corbion N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lubrizol Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zimmer Biomet Holdings Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson and Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us